Hepatitis C, Chronic

Showing 1 - 25 of 338

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Chronic Hepatitis C Virus, Hepatitis C, Chronic, Hepatitis C Trial in Bucuresti (Bemnifosbuvir, Ruzasvir)

Recruiting
  • Chronic Hepatitis C Virus
  • +4 more
  • Bucuresti, BUC, Romania
    Atea Study Site
Jun 15, 2023

Population in Improving Eearly Diagnosis Efficancy in Chinese

Recruiting
  • Carcinoma, Hepatocellular
  • +4 more
  • Liver cancer surveillance every 3 months
  • +2 more
  • Shanghai, Shanghai, China
    Department of Infectious Diseases , Ruijin Hospital, Shanghai Ji
May 13, 2023

Occult Hepatitis C Virus Infection in Patients Born Before 1969

Not yet recruiting
  • Hepatitis C, Chronic
  • +2 more
  • Meridan Bioscience Point of Care test against HCV antibodies
  • (no location specified)
Apr 2, 2023

Diabetes, Hepatitis C, Chronic, Cardiovascular Diseases Trial run by the National Institute of Diabetes and Digestive and Kidney

Recruiting
  • Diabetes Mellitus
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 27, 2023

Hepatitis C, Chronic, Pregnancy; Infection Trial in Pittsburgh (Sofosbuvir/Velpatasvir 400 MG-100 MG Oral Tablet)

Recruiting
  • Hepatitis C, Chronic
  • Pregnancy; Infection
  • Sofosbuvir/Velpatasvir 400 MG-100 MG Oral Tablet
  • Denver, Colorado
  • +4 more
Dec 3, 2022

Hepatitis C, Chronic Trial in Carlsbad (ISIS 14803)

Completed
  • Hepatitis C, Chronic
  • ISIS 14803
  • Carlsbad, California
    Isis Pharmaceuticals
Dec 1, 2022

Hepatitis C, Chronic Trial in United States (ISIS 14803, peginterferon alfa, ribavirin)

Completed
  • Hepatitis C, Chronic
  • ISIS 14803, peginterferon alfa, ribavirin
  • Birmingham, Alabama
  • +24 more
Dec 1, 2022

Hepatitis C, Chronic Trial in Albuquerque (HCV RNA screening)

Terminated
  • Hepatitis C, Chronic
  • HCV RNA screening
  • Albuquerque, New Mexico
  • +1 more
Oct 26, 2022

Liver Cirrhosis, Hepatitis C, Chronic, Epigenetic Disorder Trial in Guadalajara, Mexico City (Prolonged-Release Pirfenidone)

Recruiting
  • Liver Cirrhosis
  • +2 more
  • Prolonged-Release Pirfenidone
  • Guadalajara, Jalisco, Mexico
  • +1 more
Sep 13, 2022

Hepatitis C, Chronic, Opioid-use Disorder Trial in Pittsburgh (Sofosbuvir/Velpatasvir)

Completed
  • Hepatitis C, Chronic
  • Opioid-use Disorder
  • Pittsburgh, Pennsylvania
    Magee Womens Hospital of UPMC
Aug 19, 2022

Hepatitis C, Chronic, Opioid Dependence, on Agonist Therapy Trial in Bergen, Stavanger (Health care delivery)

Active, not recruiting
  • Hepatitis C, Chronic
  • Opioid Dependence, on Agonist Therapy
  • Health care delivery
  • Bergen, Hordaland, Norway
  • +1 more
Aug 5, 2022

Eliminating HCV Infection Among PWUD

Recruiting
  • Hepatitis C, Chronic
  • Drug Use
  • Vancouver, British Columbia, Canada
    Vancouver Infectious Diseases Centre
Jul 22, 2022

Hepatitis C, Chronic Trial in Taiwan (P1101 + Ribavirin)

Recruiting
  • Hepatitis C, Chronic
  • P1101 + Ribavirin
  • Chiayi City, Taiwan
  • +7 more
Jun 30, 2022

Evaluating the Chain of Addiction Care (CAC)

Recruiting
  • Hepatitis C, Chronic
  • Substance Use Disorders
    • Nijmegen, Gelderland, Netherlands
      Radboudumc
    May 31, 2022

    Hepatitis C, Chronic, Substance Use Disorders Trial in Roanoke (Peer specialist (PS) and vouchers)

    Not yet recruiting
    • Hepatitis C, Chronic
    • Substance Use Disorders
    • Peer specialist (PS) and vouchers
    • Roanoke, Virginia
      Carilion Clinic
    May 25, 2022

    Possible Differences in HCC Course Depending on DAA Treatment

    Recruiting
    • Carcinoma, Hepatocellular
    • +5 more
    • Direct Acting Antivirals
    • Warsaw, Mazowieckie, Poland
      Medical University of Warsaw
    May 11, 2022

    Hepatitis C, Hepatitis C, Chronic Trial in Australia (Xpert HCV Viral Load Fingerstick, Aptima HCV Quant DX Assay)

    Not yet recruiting
    • Hepatitis C
    • Hepatitis C, Chronic
    • Xpert HCV Viral Load Fingerstick
    • Aptima HCV Quant DX Assay
    • Canberra, Australian Capital Territory, Australia
    • +21 more
    Mar 30, 2022

    HCV RNA Fingerstick Assay as Useful Point of Care of Diagnostic

    Active, not recruiting
    • Hepatitis C, Chronic
    • GeneXpert HCV VL Fingerstick test
    • Bruxelles, Belgium
      CHU Saint-Pierre
    Feb 8, 2022

    Chronic Hepatitis c After Treatment With Direct Action

    Completed
    • Hepatitis C, Chronic
      • Sevilla, Spain
        Hospital Universitario Virgen macarena
      Nov 15, 2021

      Hepatitis C, Chronic Trial in Mansoura (Ledipasvir-Sofosbuvir 90 Mg-400 Mg Oral Tablet)

      Completed
      • Hepatitis C, Chronic
      • Ledipasvir-Sofosbuvir 90 Mg-400 Mg Oral Tablet
      • Mansoura, Egypt
        Mansoura University Children Hospital
      Oct 21, 2021

      Hepatitis C, Chronic Trial in Taiwan (PEGASYS 180 µg Q1W, P1101 180 µg Q1W, 48 doses, P1101 270µg Q1W, 48 doses)

      Completed
      • Hepatitis C, Chronic
      • PEGASYS 180 µg Q1W
      • +3 more
      • Changhua, Taiwan
      • +12 more
      Oct 7, 2021

      Multidisciplinary Support Program in Chronic Hepatitis C

      Completed
      • Hepatitis C, Chronic
      • Multidisciplinary support program
      • Barcelona, Spain
        Hospital del Mar
      Sep 15, 2021

      Hepatitis C, Chronic Trial in Pittsburgh (Sofosbuvir-Velpatasvir Drug Combination)

      Recruiting
      • Hepatitis C, Chronic
      • Sofosbuvir-Velpatasvir Drug Combination
      • Pittsburgh, Pennsylvania
        University of Pittsburgh, Magee Womens Hospital
      Sep 3, 2021

      Health Literacy and HCV Knowledge on HCV Treatment Willingness

      Completed
      • Hepatitis C
      • +2 more
        • San Diego, California
          Owen Clinic - University of California, San Diego
        Sep 1, 2021

        DAA Uptake in Controlling HCV Epidemic and Modeling

        Recruiting
        • Hepatitis C
        • +2 more
          • San Diego, California
            Owen Clinic-University of California, San Diego
          Sep 1, 2021